Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01447342 · ClinicalTrials.gov registry record · Phase 2
A Study to Evaluate the Safety and Effectiveness of the Cryo-Touch II Device for the Treatment of Forehead and/or Glabellar Lines
A Phase 2 study, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 54
- Enrollment target
NCT01447342 is a Phase 2 study that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 54 participants.
The verdict
NCT01447342, a Phase 2 study, has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 54 participants
- Enrollment target
Study Summary
A prospective, non-randomized, multicenter study to evaluate the safety and effectiveness of the cryo-touch II device for the treatment of forehead and/or glabellar lines
Interventions
- DEVICE Cryo-Touch II
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2011-09 |
| Est. Completion | 2012-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01447342
The ClinicalTrials.gov registry entry for NCT01447342 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pacira Pharmaceuticals, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cryo-Touch II is the first listed.
NCT01447342 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01447342 about?
NCT01447342 is a clinical study titled "A Study to Evaluate the Safety and Effectiveness of the Cryo-Touch II Device for the Treatment of Forehead and/or Glabellar Lines". A prospective, non-randomized, multicenter study to evaluate the safety and effectiveness of the cryo-touch II device for the treatment of forehead and/or glabellar lines
What is the current status of trial NCT01447342?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 54 participants. The study started on 2011-09. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01447342?
The interventions under investigation include: Cryo-Touch II (DEVICE).
Who is sponsoring clinical trial NCT01447342?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.